| Kristine E Schmaltz, MD | |
|
1213 24th St, Suite 700, Anacortes, WA 98221-2592 | |
| (360) 293-5142 | |
| (390) 299-2043 |
| Full Name | Kristine E Schmaltz |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 40 Years |
| Location | 1213 24th St, Anacortes, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932268760 | NPI | - | NPPES |
| 34072 | Other | WA | REGENCE BLUE SHIELD |
| W103051 | Other | WA | TRICARE |
| 064973001 | Other | WA | GROUP HEALTH |
| 8500043 | Medicaid | WA | |
| 33481 | Other | WA | LABOR AND INDUSTRIES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD00026417 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Skagit Valley Hospital | Mount vernon, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Public Hospital Dist No 1 Skagit | 6800793522 | 248 |
News Archive
According to new research from the UK the reduced air pressure and oxygen levels experienced by travellers on long flights are not responsible for the formation of deadly blood clots often referred to as "economy class syndrome".
A University of Southern California - USC review of published research has found no evidence that early episodes of schizophrenia without medication result in long-term harm for patients, casting doubt on the practice to immediately medicate for a year.
Los Angeles Times: "California's largest for-profit health insurer is moving to dramatically raise rates for customers with individual policies, setting off a furor among policyholders and prompting state insurance regulators to investigate.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
The results of this research, involving a study of the activity of the protein interleukin 1 in the brain, comprise not only a breakthrough in understanding the regulation of bone density by the brain but also hold promise for the development of future treatment for osteoporosis, say the researchers.
› Verified 2 days ago
| Entity Name | Public Hospital District No 2 Skagit County Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740203967 PECOS PAC ID: 1153225198 Enrollment ID: O20031121000440 |
News Archive
According to new research from the UK the reduced air pressure and oxygen levels experienced by travellers on long flights are not responsible for the formation of deadly blood clots often referred to as "economy class syndrome".
A University of Southern California - USC review of published research has found no evidence that early episodes of schizophrenia without medication result in long-term harm for patients, casting doubt on the practice to immediately medicate for a year.
Los Angeles Times: "California's largest for-profit health insurer is moving to dramatically raise rates for customers with individual policies, setting off a furor among policyholders and prompting state insurance regulators to investigate.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
The results of this research, involving a study of the activity of the protein interleukin 1 in the brain, comprise not only a breakthrough in understanding the regulation of bone density by the brain but also hold promise for the development of future treatment for osteoporosis, say the researchers.
› Verified 2 days ago
| Entity Name | Public Hospital Dist No 1 Skagit |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023332749 PECOS PAC ID: 6800793522 Enrollment ID: O20040309001059 |
News Archive
According to new research from the UK the reduced air pressure and oxygen levels experienced by travellers on long flights are not responsible for the formation of deadly blood clots often referred to as "economy class syndrome".
A University of Southern California - USC review of published research has found no evidence that early episodes of schizophrenia without medication result in long-term harm for patients, casting doubt on the practice to immediately medicate for a year.
Los Angeles Times: "California's largest for-profit health insurer is moving to dramatically raise rates for customers with individual policies, setting off a furor among policyholders and prompting state insurance regulators to investigate.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
The results of this research, involving a study of the activity of the protein interleukin 1 in the brain, comprise not only a breakthrough in understanding the regulation of bone density by the brain but also hold promise for the development of future treatment for osteoporosis, say the researchers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristine E Schmaltz, MD 1213 24th St, Suite 700, Anacortes, WA 98221-2592 Ph: (360) 293-5142 | Kristine E Schmaltz, MD 1213 24th St, Suite 700, Anacortes, WA 98221-2592 Ph: (360) 293-5142 |
News Archive
According to new research from the UK the reduced air pressure and oxygen levels experienced by travellers on long flights are not responsible for the formation of deadly blood clots often referred to as "economy class syndrome".
A University of Southern California - USC review of published research has found no evidence that early episodes of schizophrenia without medication result in long-term harm for patients, casting doubt on the practice to immediately medicate for a year.
Los Angeles Times: "California's largest for-profit health insurer is moving to dramatically raise rates for customers with individual policies, setting off a furor among policyholders and prompting state insurance regulators to investigate.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
The results of this research, involving a study of the activity of the protein interleukin 1 in the brain, comprise not only a breakthrough in understanding the regulation of bone density by the brain but also hold promise for the development of future treatment for osteoporosis, say the researchers.
› Verified 2 days ago
Michael D Sible, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1213 24th St, Suite 700, Anacortes, WA 98221 Phone: 360-293-5142 Fax: 390-299-2043 | |
Rodger W Althoff, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1211 24th St, Anacortes, WA 98221 Phone: 360-299-5142 Fax: 360-299-2043 | |
Dr. Mark N Donovan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1213 24th St Ste 700, Anacortes, WA 98221 Phone: 360-293-5412 Fax: 360-299-2043 |